Across TCGA pan-cancer cohorts, RPL7P28 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RPL7P28 data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RPL7P28 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPL7P28 expression acts as an unfavorable survival marker, although some lineages such as SKCM and BLCA show a favorable association.
SKCM, BLCA, and UVM are the cancer types where RPL7P28 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.